1. GSK

    0 Comments Leave a Comment

    1-3 of 3

    1. Mentioned In 3 Articles

    5. 1-3 of 3
  1. Search:

  2. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content

  3. Related Topics

    1. GSK announces Board and Committee Changes
      10 articles also mentioned MDC Partners
    2. Moncef M. Slaoui, Ph.D. Joins Moderna's Board of Directors
      8 articles also mentioned Board of Directors
    3. GlaxoSmithKline Falls to Bottom of Good Governance Survey
      6 articles also mentioned Emma Walmsley
    4. Novan Appoints Paula Brown Stafford, Chief Development Officer, to Board of Directors
      5 articles also mentioned Leadership
    5. GlaxoSmithKline Buys Novartis out of Their Joint Venture for $13 Billion
      3 articles also mentioned Pfizer

  4. Quotes about GSK

    1. The proposed transaction addresses one of our key capital allocation priorities and will allow GSK shareholders to capture the full value of one of the world's leading consumer healthcare businesses.
      In GlaxoSmithKline Buys Novartis out of Their Joint Venture for $13 Billion
    2. While our consumer healthcare joint venture with GSK is progressing well, the time is right for Novartis to divest a non-core asset at an attractive price.
      In GlaxoSmithKline Buys Novartis out of Their Joint Venture for $13 Billion
    3. In the short-term, teaming up with Pfizer means GSK will become over the counter market leader in pretty much all major geographies around the world, and the partnership should bring significant cost savings too.
      In Pharma Giant GlaxoSmithKline Signs Mega Deal With Pfizer That Could Change the Face of Global Healthcare